• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

协调希望:通过 CCL2/CCR2 轴探索骨关节炎旋律,寻找创新治疗途径。

Harmonizing hope: navigating the osteoarthritis melody through the CCL2/CCR2 axis for innovative therapeutic avenues.

机构信息

Department of Internal Medicine, School of Medicine, Ali-Ibn Abi-Talib Hospital, Rafsanjan University of Medical Sciences, Rafsanjan, Iran.

Department of Immunology, School of Medicine, Rafsanjan University of Medical Sciences, Rafsanjan, Iran.

出版信息

Front Immunol. 2024 Jul 15;15:1387651. doi: 10.3389/fimmu.2024.1387651. eCollection 2024.

DOI:10.3389/fimmu.2024.1387651
PMID:39076996
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11284107/
Abstract

Osteoarthritis (OA) is characterized by a complex interplay of molecular signals orchestrated by the CCL2/CCR2 axis. The pathogenesis of OA has been revealed to be influenced by a multifaceted effect of CCL2/CCR2 signaling on inflammation, cartilage degradation, and joint homeostasis. The CCL2/CCR2 axis promotes immune cell recruitment and tips the balance toward degeneration by influencing chondrocyte behavior. Insights into these intricate pathways will offer novel therapeutic approaches, paving the way for targeted interventions that may redefine OA management in the future. This review article explores the molecular symphony through the lens of the CCL2/CCR2 axis, providing a harmonious blend of current knowledge and future directions on OA treatment. Furthermore, in this study, through a meticulous review of recent research, the key players and molecular mechanisms that amplify the catabolic cascade within the joint microenvironment are identified, and therapeutic approaches to targeting the CCL2/CCR axis are discussed.

摘要

骨关节炎(OA)的特征是分子信号的复杂相互作用,由 CCL2/CCR2 轴协调。OA 的发病机制已被揭示受到 CCL2/CCR2 信号对炎症、软骨降解和关节动态平衡的多方面影响。CCL2/CCR2 轴通过影响软骨细胞行为促进免疫细胞募集,并使平衡向退化倾斜。深入了解这些复杂的途径将提供新的治疗方法,为未来可能重新定义 OA 管理的靶向干预铺平道路。本文通过 CCL2/CCR2 轴的视角探索了分子交响乐,提供了 OA 治疗方面当前知识和未来方向的和谐融合。此外,在这项研究中,通过对最近研究的细致回顾,确定了在关节微环境中放大分解代谢级联的关键参与者和分子机制,并讨论了针对 CCL2/CCR 轴的治疗方法。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f2ee/11284107/b38b5cdd5e71/fimmu-15-1387651-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f2ee/11284107/d979408f0753/fimmu-15-1387651-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f2ee/11284107/89d5c54ef564/fimmu-15-1387651-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f2ee/11284107/b38b5cdd5e71/fimmu-15-1387651-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f2ee/11284107/d979408f0753/fimmu-15-1387651-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f2ee/11284107/89d5c54ef564/fimmu-15-1387651-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f2ee/11284107/b38b5cdd5e71/fimmu-15-1387651-g003.jpg

相似文献

1
Harmonizing hope: navigating the osteoarthritis melody through the CCL2/CCR2 axis for innovative therapeutic avenues.协调希望:通过 CCL2/CCR2 轴探索骨关节炎旋律,寻找创新治疗途径。
Front Immunol. 2024 Jul 15;15:1387651. doi: 10.3389/fimmu.2024.1387651. eCollection 2024.
2
Chemokine (C-C Motif) Ligand 2/Chemokine Receptor 2 (CCR2) Axis Blockade to Delay Chondrocyte Hypertrophy as a Therapeutic Strategy for Osteoarthritis.趋化因子(C-C 基序)配体 2/趋化因子受体 2(CCR2)轴抑制软骨细胞肥大作为骨关节炎的治疗策略。
Med Sci Monit. 2021 Dec 8;27:e930053. doi: 10.12659/MSM.930053.
3
CCL2/CCR2, but not CCL5/CCR5, mediates monocyte recruitment, inflammation and cartilage destruction in osteoarthritis.CCL2/CCR2而非CCL5/CCR5介导骨关节炎中单核细胞募集、炎症及软骨破坏。
Ann Rheum Dis. 2017 May;76(5):914-922. doi: 10.1136/annrheumdis-2016-210426. Epub 2016 Dec 13.
4
The role of MCP-1-CCR2 ligand-receptor axis in chondrocyte degradation and disease progress in knee osteoarthritis.MCP-1-CCR2配体-受体轴在膝关节骨关节炎软骨细胞降解及疾病进展中的作用
Biol Res. 2015 Nov 17;48:64. doi: 10.1186/s40659-015-0057-0.
5
Soluble CCR2 gene therapy controls joint inflammation, cartilage damage, and the progression of osteoarthritis by targeting MCP-1 in a monosodium iodoacetate (MIA)-induced OA rat model.可溶性 CCR2 基因治疗通过靶向 MCP-1 控制单核细胞趋化蛋白-1(MCP-1)在碘乙酸单钠(MIA)诱导的骨关节炎大鼠模型中的关节炎症、软骨损伤和骨关节炎进展。
J Transl Med. 2022 Sep 23;20(1):428. doi: 10.1186/s12967-022-03515-3.
6
CCL2 and CCR2 regulate pain-related behaviour and early gene expression in post-traumatic murine osteoarthritis but contribute little to chondropathy.CCL2和CCR2调节创伤后小鼠骨关节炎中与疼痛相关的行为和早期基因表达,但对软骨病的影响很小。
Osteoarthritis Cartilage. 2017 Mar;25(3):406-412. doi: 10.1016/j.joca.2016.10.008. Epub 2016 Oct 13.
7
Role of the CCL2-CCR2 signalling axis in cancer: Mechanisms and therapeutic targeting.CCL2-CCR2 信号轴在癌症中的作用:机制与治疗靶点。
Cell Prolif. 2021 Oct;54(10):e13115. doi: 10.1111/cpr.13115. Epub 2021 Aug 31.
8
Acupuncture reduces pain in rats with osteoarthritis by inhibiting MCP2/CCR2 signaling pathway.针灸通过抑制 MCP2/CCR2 信号通路减轻骨关节炎大鼠的疼痛。
Exp Biol Med (Maywood). 2020 Dec;245(18):1722-1731. doi: 10.1177/1535370220952342. Epub 2020 Sep 2.
9
CCL2 But Not CCR2 Is Required for Spontaneous Articular Cartilage Regeneration Post-Injury.CCL2 而非 CCR2 对于损伤后自发性关节软骨再生是必需的。
J Orthop Res. 2019 Dec;37(12):2561-2574. doi: 10.1002/jor.24444. Epub 2019 Aug 30.
10
Role of CCL2/CCR2 axis in the immunopathogenesis of rheumatoid arthritis: Latest evidence and therapeutic approaches.CCL2/CCR2 轴在类风湿关节炎免疫发病机制中的作用:最新证据和治疗方法。
Life Sci. 2021 Mar 15;269:119034. doi: 10.1016/j.lfs.2021.119034. Epub 2021 Jan 13.

引用本文的文献

1
Insights into Vascular Changes in Hip Degenerative Disorders: An Observational Study.髋部退行性疾病血管变化的见解:一项观察性研究。
J Clin Med. 2025 Aug 18;14(16):5845. doi: 10.3390/jcm14165845.
2
Therapeutic targeting of tumour-associated macrophage receptors.肿瘤相关巨噬细胞受体的治疗靶向作用
Immunother Adv. 2025 Mar 11;5(1):ltaf009. doi: 10.1093/immadv/ltaf009. eCollection 2025.
3
Mechanical Load-Induced Upregulation of Talin2 through Non-Canonical Deubiquitination of OTUB1 Drives Facet Joint Osteoarthritis Pathogenesis.

本文引用的文献

1
The role of monocyte/macrophage chemokines in pathogenesis of osteoarthritis: A review.单核细胞/巨噬细胞趋化因子在骨关节炎发病机制中的作用:综述。
Int J Immunogenet. 2024 Jun;51(3):130-142. doi: 10.1111/iji.12664. Epub 2024 Mar 10.
2
Co-treatment with Oral Duloxetine and Intraarticular Injection of Corticosteroid plus Hyaluronic Acid Reduces Pain in the Treatment of Knee Osteoarthritis.口服度洛西汀与关节内注射皮质类固醇加透明质酸联合治疗可减轻膝骨关节炎疼痛。
Pain Physician. 2024 Jan;27(1):E45-E53.
3
Role of Interleukin-17 family cytokines in disease severity of patients with knee osteoarthritis.
机械负荷通过OTUB1的非经典去泛素化诱导Talin2上调驱动小关节骨关节炎发病机制。
Adv Sci (Weinh). 2025 Jul;12(25):e2501046. doi: 10.1002/advs.202501046. Epub 2025 Apr 25.
4
Chemokine CCL2 and its receptor CCR2 in different age groups of patients with COVID-19.新型冠状病毒肺炎患者不同年龄组趋化因子 CCL2 及其受体 CCR2 的表达。
BMC Immunol. 2024 Oct 26;25(1):72. doi: 10.1186/s12865-024-00662-8.
白细胞介素-17家族细胞因子在膝骨关节炎患者疾病严重程度中的作用。
Adv Rheumatol. 2024 Jan 24;64(1):11. doi: 10.1186/s42358-024-00351-5.
4
Targeting the CCL2-CCR2 signaling pathway: potential implications of statins beyond cardiovascular diseases.靶向 CCL2-CCR2 信号通路:他汀类药物在心血管疾病之外的潜在影响。
J Pharm Pharmacol. 2024 Jan 27;76(2):138-153. doi: 10.1093/jpp/rgad112.
5
Immunomodulatory Strategies for Cartilage Regeneration in Osteoarthritis.骨关节炎软骨再生的免疫调节策略。
Tissue Eng Part A. 2024 Apr;30(7-8):259-271. doi: 10.1089/ten.TEA.2023.0255. Epub 2024 Jan 24.
6
CircIRAK3 exerts negative feedback regulation on inflammation by binding to HNRNP U and destabilizing proinflammatory cytokine mRNA in osteoarthritis and chondrogenesis.环状 RNA IRAK3 通过与 HNRNP U 结合并使骨关节炎和软骨生成中的促炎细胞因子 mRNA 不稳定,从而对炎症发挥负反馈调节作用。
Int J Biol Macromol. 2024 Jan;256(Pt 2):128453. doi: 10.1016/j.ijbiomac.2023.128453. Epub 2023 Nov 26.
7
Reprogramming macrophages via immune cell mobilized hydrogel microspheres for osteoarthritis treatments.通过免疫细胞动员水凝胶微球重编程巨噬细胞用于骨关节炎治疗。
Bioact Mater. 2023 Oct 12;32:242-259. doi: 10.1016/j.bioactmat.2023.09.010. eCollection 2024 Feb.
8
CCR2: A characteristic chemokine receptor in normal and pathological intestine.CCR2:正常和病理肠道中的特征性趋化因子受体。
Cytokine. 2023 Sep;169:156292. doi: 10.1016/j.cyto.2023.156292. Epub 2023 Jul 10.
9
Research Progress on the Pathogenesis of Knee Osteoarthritis.膝关节骨关节炎发病机制的研究进展。
Orthop Surg. 2023 Sep;15(9):2213-2224. doi: 10.1111/os.13809. Epub 2023 Jul 12.
10
CC chemokines and receptors in osteoarthritis: new insights and potential targets.CC 趋化因子及其受体在骨关节炎中的作用:新的认识和潜在靶点。
Arthritis Res Ther. 2023 Jul 3;25(1):113. doi: 10.1186/s13075-023-03096-6.